Société des Industries Pharmaceutiques de Tunisie - Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Société des Industries Pharmaceutiques de Tunisie -.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Pharmaceuticals earnings growth | 19.5% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | None |
Last updated | n/a |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2021 | 10 | -22 | -23 | -17 | 1 |
6/30/2020 | 20 | -17 | -15 | -15 | N/A |
3/31/2020 | 22 | -16 | -11 | -10 | N/A |
12/31/2019 | 24 | -15 | -7 | -6 | N/A |
6/30/2019 | 29 | -17 | -2 | -1 | N/A |
3/31/2019 | 31 | -15 | 0 | 1 | N/A |
12/31/2018 | 33 | -14 | 2 | 3 | N/A |
9/30/2018 | 36 | -11 | 1 | 1 | N/A |
6/30/2018 | 38 | -8 | 0 | 0 | N/A |
3/31/2018 | 38 | -8 | -2 | -1 | N/A |
12/31/2017 | 37 | -8 | -3 | -3 | N/A |
9/30/2017 | 39 | -7 | -1 | 0 | N/A |
6/30/2017 | 40 | -6 | 2 | 2 | N/A |
3/31/2017 | 41 | -5 | 2 | 2 | N/A |
12/31/2016 | 43 | -4 | 2 | 2 | N/A |
9/30/2016 | 42 | -4 | 1 | 2 | N/A |
6/30/2016 | 42 | -4 | 1 | 2 | N/A |
3/31/2016 | 43 | -4 | 2 | 3 | N/A |
12/31/2015 | 45 | -3 | 3 | 4 | N/A |
9/30/2015 | 44 | -4 | 2 | 2 | N/A |
6/30/2015 | 43 | -5 | 1 | 1 | N/A |
3/31/2015 | 42 | -6 | -3 | -2 | N/A |
12/31/2014 | 41 | -7 | -6 | -6 | N/A |
9/30/2014 | 41 | -6 | -5 | -4 | N/A |
6/30/2014 | 41 | -5 | -4 | -2 | N/A |
3/31/2014 | 43 | -3 | N/A | 1 | N/A |
12/31/2013 | 45 | -1 | N/A | 5 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if SIPHA's forecast earnings growth is above the savings rate (14.7%).
Earnings vs Market: Insufficient data to determine if SIPHA's earnings are forecast to grow faster than the TN market
High Growth Earnings: Insufficient data to determine if SIPHA's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if SIPHA's revenue is forecast to grow faster than the TN market.
High Growth Revenue: Insufficient data to determine if SIPHA's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if SIPHA's Return on Equity is forecast to be high in 3 years time